Carbon-carbon and carbon-nitrogen bond formation mediated by ruthenium (II) complexes: synthesis of (1H)-isoquinolinium derivatives, Organometallics, vol.12, p.4464, 1993. ,
Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis, Nature (Lond), vol.399, pp.809-813, 1999. ,
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer, Br J Cancer, vol.86, pp.1652-1657, 2002. ,
Ruthenium in medicine: current clinical uses and future prospects, Platinum Metals Rev, vol.45, p.62, 2001. ,
Arene ruthenium (II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium (III) chlorides, J Chem Soc Dalton Trans, vol.2, pp.233-241, 1974. ,
Bax. The pro-apoptotic Bcl-2 family member, Bax, Int J Biochem Cell Biol, vol.30, pp.647-650, 1998. ,
Ruthenium metallopharmaceuticals, Coord Chem Rev, vol.236, p.209, 2003. ,
Non-platinum chemotherapeutic metallopharmaceuticals, Chem Rev, vol.99, pp.2511-2534, 1999. ,
Cisplatinum and taxol induce different patterns of p53 phosphorylation, Neoplasia, vol.3, pp.10-16, 2001. ,
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes, Pharmacol Ther, vol.34, pp.155-166, 1987. ,
, The role of p53 in chemosensitivity and radiosensitivity, vol.22, pp.7486-7495, 2003.
gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents, Cancer Res, vol.54, pp.5824-5830, 1994. ,
An effective route to cycloruthenated N-ligands under mild conditions, Organometallics, vol.18, p.2390, 1999. ,
Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells, Cancer Res, vol.39, pp.1793-1797, 1979. ,
The CD95 (APO-1/ Fas) system mediates drug-induced apoptosis in neuroblastoma cells, Cancer Res, vol.57, pp.3823-3829, 1997. ,
A subset of tumorderived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain, Mol Cell Biol, vol.21, pp.1874-1887, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-02360323
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatininduced DNA damage, Nature (Lond), vol.399, pp.806-809, 1999. ,
regulation by Chk1 in response to DNA damage, Mol Cell Biol, vol.23, pp.8161-8171, 2003. ,
Is cisplatin-induced cell death always produced by apoptosis?, Mol Pharmacol, vol.59, pp.657-663, 2001. ,
Metals in medicine, Angew Chem Int Ed, vol.38, pp.1512-1531, 1999. ,
The biochemistry of apoptosis, Nature (Lond), vol.407, pp.770-776, 2000. ,
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells, Mol Pharmacol, vol.64, pp.466-473, 2003. ,
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance, Cancer Res, vol.60, pp.1312-1316, 2000. ,
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour, Nat Genet, vol.25, pp.47-54, 2000. ,
Inhibition of cancer cell growth by ruthenium(II) arene complexes, J Med Chem, vol.44, pp.3616-3621, 2001. ,
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J Immunol Methods, vol.139, pp.271-279, 1991. ,
Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance, J Med Chem, vol.44, pp.4661-4667, 2001. ,
Ovarian cancer, part II: treatment, Curr Probl Cancer, vol.16, pp.61-126, 1992. ,
is required for survival and maintenance of CNS neurons, J Neurosci, vol.22, pp.9800-9809, 2002. ,
The p53 pathway, J Pathol, vol.187, pp.112-126, 1999. ,
Cyclopalladated compounds as chemotherapeutic agents: antitumor activity against a murine melanoma cell line, Int J Cancer, vol.107, pp.498-504, 2003. ,
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes Dev, vol.14, pp.289-300, 2000. ,
Experiments with Gene Fusion, 1984. ,
Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL, J Biol Chem, vol.271, pp.22764-22772, 1996. ,
DNA damage enables p73, Nature (Lond), vol.399, pp.734-735, 1999. ,
Current status of platinum-based antitumor drugs, Chem Rev, vol.99, pp.2451-2466, 1999. ,
is a universal inhibitor of cyclin kinases, Nature (Lond), vol.366, pp.701-704, 1993. ,
is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage, Nature (Lond), vol.399, pp.814-817, 1999. ,
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1, Mol Cell Biol, vol.21, pp.4129-4139, 2001. ,